NCT01530906

Brief Summary

Bulimia nervosa is defined by recurrent episodes of binge eating followed by compensatory behaviors (such as induced vomiting) to prevent weight gain. It is a common and serious disease for which current treatment strategies have to be improved. The aim of this study is to assess whether a transcranial magnetic stimulation reduces bulimic symptoms in a short term.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 1, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 10, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

December 3, 2014

Status Verified

February 1, 2012

Enrollment Period

3.2 years

First QC Date

February 1, 2012

Last Update Submit

December 2, 2014

Conditions

Keywords

Eating disordersBulimiarTMSTreatment

Outcome Measures

Primary Outcomes (1)

  • Efficiency of rTMS in bulimia

    The objective of this project is to assess whether a program of repetitive transcranial magnetic stimulation (rTMS) under high frequency at the left DLPFC reduces bulimic symptoms in the short term. To do this we will count the number of binge during the 15 days following the last session of rTMS.

    At J0 and J45 (maximum of 45 days between the inclusion visit and the final visit)

Study Arms (2)

rTMS

EXPERIMENTAL

patients included in this arm will receive 10 sessions of transcranial magnetic stimulation (10 TMS sessions of 20 trains of 5s with 55s interval cross train, at a frequency of 10 Hz and 110% of motor threshold intensity of the left DLPFC). Fifty percent of patients will be included in this arm. During the first and last session a food challenge task will be administered before and after rTMS. Salivary cortisol level will be assessed throughout the protocol Intervention: Repetitive transcranial Magnetic Stimulation (rTMS)

Procedure: Repetitive transcranial Magnetic Stimulation (rTMS)

rTMS SHAM

PLACEBO COMPARATOR

Transcranial magnetic stimulation SHAM Intervention: Repetitive transcranial Magnetic Stimulation SHAM Fifty percent of patients will be included in this arm. During the first and last session a food challenge task will be administered before and after rTMS. Salivary cortisol level will be assessed throughout the protocol

Procedure: Repetitive transcranial Magnetic Stimulation SHAM

Interventions

10 TMS sessions of 20 trains of 5s with 55s interval cross train, at a frequency of 10 Hz and 110% of motor threshold intensity of the left DLPFC.

Also known as: Magstim rapid2, Reference 3576-23-05
rTMS

Sham treatment will be performed with a placebo coil. The same coil as coil used for rTMS, but it does not deliver magnetic field.

Also known as: Magstim Company
rTMS SHAM

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnostic of bulimia nervosa (DSM IV)
  • Women (18-40 years old)
  • right-handed
  • treated by fluoxetine (60mg/j) or escitalopram (30mg/j) for at least 3 weeks.
  • use effective contraceptive measures

You may not qualify if:

  • Current anorexia as DSM IV criteria
  • Current psychiatric disorder unstabilized
  • Taking corticosteroid
  • History of seizures or epilepsy
  • History of head trauma, cerebral pathology
  • Serious physical illness unstabilized
  • Prior use of the TMS
  • pregnancy or breastfeeding
  • Somatic disease may affect cognitive abilities and brain structures
  • Loss of personal capacity resulting in state protection
  • Deprivation of liberty by judicial or administrative decision
  • Patients with pacemakers, defibrillator, neuro stimulator implanted.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montpellier University Hospital

Montpellier, 34295, France

RECRUITING

Related Publications (3)

  • Van den Eynde F, Guillaume S, Broadbent H, Campbell IC, Schmidt U. Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study. Eur Psychiatry. 2013 Feb;28(2):98-101. doi: 10.1016/j.eurpsy.2011.06.002. Epub 2011 Aug 30.

  • Van den Eynde F, Broadbent H, Guillaume S, Claudino A, Campbell IC, Schmidt U. Handedness, repetitive transcranial magnetic stimulation and bulimic disorders. Eur Psychiatry. 2012 May;27(4):290-3. doi: 10.1016/j.eurpsy.2010.08.015. Epub 2010 Nov 9.

  • Guillaume S, Gay A, Jaussent I, Sigaud T, Billard S, Attal J, Seneque M, Galusca B, Thiebaut S, Massoubre C, Courtet P. Improving decision-making and cognitive impulse control in bulimia nervosa by rTMS: An ancillary randomized controlled study. Int J Eat Disord. 2018 Sep;51(9):1103-1106. doi: 10.1002/eat.22942. Epub 2018 Sep 21.

MeSH Terms

Conditions

Bulimia NervosaFeeding and Eating DisordersBulimia

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsHyperphagia

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Sebastien Guillaume

    Montpellier University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

sebastien Guillaume, MD Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2012

First Posted

February 10, 2012

Study Start

January 1, 2012

Primary Completion

March 1, 2015

Study Completion

September 1, 2015

Last Updated

December 3, 2014

Record last verified: 2012-02

Locations